Ethicon Endo-Surgery, a subsidiary of Johnson & Johnson, has announced the availability of its ENSEAL G2 articulating tissue sealer in the US. Ethicon Endo-Surgery claims ENSEAL G2 is the first and only articulating advanced energy device ...
Tags: Ethicon Endo-Surgery
The Netherlands-based Royal DSM has announced a partnership with US-based BiO2 Medical to supply DSM’s proprietary ComfortCoat lubricious coating and its coating application expertise for use in BiO2 Medical’s Angel catheter. ...
US-based Cochlear has announced that an advisory committee to the US Food and Drug Administration (FDA) voted favorably on the Cochlear Nucleus Hybrid L24 implant system. This is a first of its kind system designed for the treatment of ...
Iceland-based Kerecis has obtained 510(k) approval from the US Food and Drug Administration (FDA) to market its fish-skin, Omega3, tissue-regeneration technology for the treatment of chronic wounds in the US. The company will market the ...
Tags: Kerecis, PDA, Fish-Skin Technology, chronic wounds
Hologic, a manufacturer of diagnostic products, medical imaging systems and surgical products, has announced that the US Food and Drug Administration (FDA) has approved the Aptima HPV 16 18/45 genotype assay for use on the company's fully ...
Tags: aptima HPV, Hologic, panther system
Medtronic has obtained the US Food and Drug Administration (FDA) approval for its Lead Integrity Alert (LIA) software for use with non-Medtronic leads to detect defibrillator lead issues. LIA software has been approved by the FDA to ...
Tags: Medtronic, PDA, LIA, non-medtronic
NanoBio Systems, a medical sensor startup company, has announced the successful measurement of glucose in saliva of human test subjects using a disposable nanotechnology-based sensor platform and simple, portable electronics. Limited ...
Topera, a US-based medical device company, has announced the US Food and Drug Administration (FDA) 510(k) approval and commercial availability of its FIRMap catheter and RhythmView 3D mapping workstation. For clinicians, the RhythmView 3D ...
Tags: Topera, clinician, firmap catheter, FDA approval
The US Food and Drug Administration (FDA) has approved Sunovion Pharmaceuticals' (Sunovion) antiepileptic drug (AED) Aptiom (eslicarbazepine acetate) for the treatment of partial-onset seizures in patients with epilepsy. According to the ...
Tags: FDA, Sunovion, partial-onset seizure, epilepsy
The US Food and Drug Administration (FDA) has given 510(k) clearance for the marketing of Iceland-based Kerecis' proprietary fish-skin, omega-3, tissue-regeneration product for treating chronic wounds in the US. The product known as ...
Tags: Kerecis, Fish-Skin treatment, chronic wounds, FDA
US-based Fujifilm SonoSite has received 510(k) clearance from the US Food and Drug Administration (FDA) for its X-Porte ultrasound kiosk, a new generation of point-of-care ultrasound. This integrates advanced signal processing for ...
The US Food and Drug Administration (FDA) has proposed measures that would potentially eliminate artificial trans fat in processed foods as it poses health risks. The agency has announced its preliminary determination that partially ...
Tags: Fat Levels, Processed Foods
Laboratory Corporation of America Holdings (LabCorp) has announced that its fourth generation human immunodeficiency virus (HIV) antigen/antibody combination assay for screening of HIV infection is now available. In addition to the HIV ...
Tags: hiv, hiv antigen, hiv cure, hiv assays
US-based medical device company Veniti has obtained CE Mark approval for its Veniti Vici venous stent, designed for venous obstruction treatment. The company has also obtained CE Mark approval for its Veniti Veni RF plus ablation system, ...
Tags: venous obstruction treatment, varicose vein ablation product, heal
W. L. Gore & Associates (Gore) has obtained an approval from the US Food and Drug Administration (FDA) for its 25cm GORE VIABAHN endoprosthesis with heparin bioactive surface. The 25cm Gore Viabahn endoprosthesis is intended to treat ...
Tags: disease heal, health, cure, fda